柔肝熄风通络汤干预糖尿病周围神经病变临床疗效及血同型半胱氨酸水平的研究
|
摘要
糖尿病周围神经病变((diabetic peripheral neuropathy,DPN)是糖尿病最常见的并发症之一,其发病率高达50%以上,常引起感觉、运动和/或自主神经机能障碍,其病因及发病机制尚未阐明。同型半胱氨酸(homocysteine,Hcy)是一种反应性血管损伤氨基酸,近几年来许多研究表明,糖尿病和血浆高Hcy水平有关,发现Hcy不但是糖尿病大血管病变的独立危险因素,同时也是DPN的重要危险因素。
目的：
1、观察柔肝熄风通络汤联合甲钴胺治疗DPN患者的临床疗效及血浆Hcy水平的变化。
2、探讨2型糖尿病(T2DM)患者学Hcy水平与中医证型的关系。
方法：
1、在良好控制血糖的基础上,将60例DPN患者随机分为两组(每组30例)。对照组予甲钴胺治疗,治疗组在对照基础上加服柔肝熄风通络汤。两组连续治疗8周后,观察所有病例的临床症状积分、神经传导速度、血糖、HbAlC、Hcy水平、肝肾功能的变化及有无毒副反应。
2、将202例T2DM忠者辨证分为阴虚热盛型、气阴两虚型和阴阳两虚型3组,测定各组患者血Hcy水平,对不同中医证型T2DM患者和T2DM合并高Hcy血症患者间血Hcy水平进行比较,并作统计学分析。
结果：
1、治疗8周后,两组病例的症状积分、血Hcy水平均较治疗均前有显著性降低(P<0.01),神经传导速度较治疗前均明显提高(P<0.01)。而治疗组在症状积分、血Hcy水平、神经传导速度及治疗有效率等方面明显优于对照组(P<0.01)；两组治疗后其血糖均有所改善,但两组无统计学意义(P>0.05)；同时均未发现明显毒副反应。
2、202例T2DM患者中有73.76%合并高Hcy血症,其中阴阳两虚组血Hcy水平最高,气阴两虚组次之,阴虚热盛组最低,差异有统计学意义(P<0.05)。对不同中医证型T2DM患者间血Hcy水平及T2DM合并高Hcy血症患者血Hcy水平进行分析比较,其结果均为：阴阳两虚组血Hcy水平最高,气阴两虚组次之,阴虚热盛组相对较低,差异均有统计学意义。
结论：
1、在良好控制血糖基础上运用柔肝熄风通络汤联合甲钻胺治疗DPN疗效较好、安全,切改善高Hcy血症优于单用甲钴胺。
2、血Hcy水平在阴虚热盛、气阴两虚、阴阳两虚3个证型中呈现递增趋势,提示高Hcy血.症与T2DM及糖尿病慢性并发症的中医病因病机存在着一定的关联性,血Hcy水平可作为T2DM中医辨证的客观参考指标之一。
Diabetic peripheral neuropathy(DPN) is one of the most common complications of diabetes mellitus, the incidence of which is up to about 50%, it causes sensory, motor, and/or autonomic dysfunction. However, the pathogenesis of DPN has still not been very clear. Homocysteine(Hcy)is regarded as a reactive vascular scathing amino acid. In recent years, many studies have demonstrated that diabetic is associated with hyperhomocysteinemia. Hey has been found that it is not only a major and independent risk factor for diabetic vascular disease but also an important risk factor for DPN.
Objective:
1、To observe the clinical therapeutic effects of Liver-Nourishing and Endogenous Wind-Stopping and Collateral-Unblocking Decoction combined with methylcobalamin in patients with DPN, and to study the changes of the plasma Hey level.
2、To investigate the relationship between plasma Hey level and TCM patterns in patients with type 2 diabetes mellitus(T2DM).
Methods:
1、Based on intensive control of blood glucose, totally 60 patients with DPN were randomly divided into the control group and the study group.30 cases were treated with methylcobalamin as the control group, while 30 cases were treated with Liver-Nourishing and Endogenous Wind-Stopping and Collateral-Unblocking Decoction additionally as the study group. The two groups were both treated for 8 weeks. Before and after treatment, all patients underwent laboratory testing including blood glucose, HbAlC, plasma Hey level, and Biochemical targets(ALT and Scr). Neurologic symptoms integral was evaluated, nerve conduction velocity (NCV) of median nerve and common peroneal nerve were performed. Comparing the change of these targets. Adverse events were observed in two groups during treatment period.
2、A total of 202 patients with T2DM was categorized into three pattern groups: yin-deficiency and excessive heat pattern, qi-yin deficiency pattern and yin-yang deficiency pattern. Plasma Hey levels of each group were detected and their relationships with the TCM patterns were given statistical analysis.
Results:
1、After 8 weeks treatment, neurologic symptoms integral and plasma Hey level were significantly lowered than those of before treatment in two groups (P<0.01). SNCV and MNCV of median nerve and common peroneal nerve were significantly increased than those of before treatment(P<0.01). Improvement of neurologic symptoms integral and NCV, decline of plasma Hcy level, the effective rate of treatment in the study group were superior to those in the control group(P<0.01). Blood glucose was decreased but not statistical significance (P>0.05). Furthermore, there was no obvious toxic side effect found in the two groups.
2> There were 73.76%of 202 T2DM patients accompanied heperhomocysteinemia. Plasma Hcy levels in patients with T2DM and T2DM accompanied heperhomocysteinemia among different pattern groups were ranked from high to low as follows:yin-yang deficiency pattern, qi-yin deficiency pattern and yin-deficiency and excessive heat pattern, the difference was statistical significance. (P＜O.05)
Conclusion:
1、Based on intensive control of blood glucose, the treatment of Liver-Nourishing and Endogenous Wind-Stopping and Collateral-Unblocking Decoction combined with methylcobalamin has a good and safe effect in patients with DPN. Simultaneously, its effect is superior to only using methylcobalamin.
2、There is certain correlation between plasma Hcy level and TCM patterns in patients with T2DM. Plasma Hcy level can be regarded as a objective index for Traditional Chinese Medicine(TCM)syndrome differentiation in T2DM.
目的：
1、观察柔肝熄风通络汤联合甲钴胺治疗DPN患者的临床疗效及血浆Hcy水平的变化。
2、探讨2型糖尿病(T2DM)患者学Hcy水平与中医证型的关系。
方法：
1、在良好控制血糖的基础上,将60例DPN患者随机分为两组(每组30例)。对照组予甲钴胺治疗,治疗组在对照基础上加服柔肝熄风通络汤。两组连续治疗8周后,观察所有病例的临床症状积分、神经传导速度、血糖、HbAlC、Hcy水平、肝肾功能的变化及有无毒副反应。
2、将202例T2DM忠者辨证分为阴虚热盛型、气阴两虚型和阴阳两虚型3组,测定各组患者血Hcy水平,对不同中医证型T2DM患者和T2DM合并高Hcy血症患者间血Hcy水平进行比较,并作统计学分析。
结果：
1、治疗8周后,两组病例的症状积分、血Hcy水平均较治疗均前有显著性降低(P<0.01),神经传导速度较治疗前均明显提高(P<0.01)。而治疗组在症状积分、血Hcy水平、神经传导速度及治疗有效率等方面明显优于对照组(P<0.01)；两组治疗后其血糖均有所改善,但两组无统计学意义(P>0.05)；同时均未发现明显毒副反应。
2、202例T2DM患者中有73.76%合并高Hcy血症,其中阴阳两虚组血Hcy水平最高,气阴两虚组次之,阴虚热盛组最低,差异有统计学意义(P<0.05)。对不同中医证型T2DM患者间血Hcy水平及T2DM合并高Hcy血症患者血Hcy水平进行分析比较,其结果均为：阴阳两虚组血Hcy水平最高,气阴两虚组次之,阴虚热盛组相对较低,差异均有统计学意义。
结论：
1、在良好控制血糖基础上运用柔肝熄风通络汤联合甲钻胺治疗DPN疗效较好、安全,切改善高Hcy血症优于单用甲钴胺。
2、血Hcy水平在阴虚热盛、气阴两虚、阴阳两虚3个证型中呈现递增趋势,提示高Hcy血.症与T2DM及糖尿病慢性并发症的中医病因病机存在着一定的关联性,血Hcy水平可作为T2DM中医辨证的客观参考指标之一。
Diabetic peripheral neuropathy(DPN) is one of the most common complications of diabetes mellitus, the incidence of which is up to about 50%, it causes sensory, motor, and/or autonomic dysfunction. However, the pathogenesis of DPN has still not been very clear. Homocysteine(Hcy)is regarded as a reactive vascular scathing amino acid. In recent years, many studies have demonstrated that diabetic is associated with hyperhomocysteinemia. Hey has been found that it is not only a major and independent risk factor for diabetic vascular disease but also an important risk factor for DPN.
Objective:
1、To observe the clinical therapeutic effects of Liver-Nourishing and Endogenous Wind-Stopping and Collateral-Unblocking Decoction combined with methylcobalamin in patients with DPN, and to study the changes of the plasma Hey level.
2、To investigate the relationship between plasma Hey level and TCM patterns in patients with type 2 diabetes mellitus(T2DM).
Methods:
1、Based on intensive control of blood glucose, totally 60 patients with DPN were randomly divided into the control group and the study group.30 cases were treated with methylcobalamin as the control group, while 30 cases were treated with Liver-Nourishing and Endogenous Wind-Stopping and Collateral-Unblocking Decoction additionally as the study group. The two groups were both treated for 8 weeks. Before and after treatment, all patients underwent laboratory testing including blood glucose, HbAlC, plasma Hey level, and Biochemical targets(ALT and Scr). Neurologic symptoms integral was evaluated, nerve conduction velocity (NCV) of median nerve and common peroneal nerve were performed. Comparing the change of these targets. Adverse events were observed in two groups during treatment period.
2、A total of 202 patients with T2DM was categorized into three pattern groups: yin-deficiency and excessive heat pattern, qi-yin deficiency pattern and yin-yang deficiency pattern. Plasma Hey levels of each group were detected and their relationships with the TCM patterns were given statistical analysis.
Results:
1、After 8 weeks treatment, neurologic symptoms integral and plasma Hey level were significantly lowered than those of before treatment in two groups (P<0.01). SNCV and MNCV of median nerve and common peroneal nerve were significantly increased than those of before treatment(P<0.01). Improvement of neurologic symptoms integral and NCV, decline of plasma Hcy level, the effective rate of treatment in the study group were superior to those in the control group(P<0.01). Blood glucose was decreased but not statistical significance (P>0.05). Furthermore, there was no obvious toxic side effect found in the two groups.
2> There were 73.76%of 202 T2DM patients accompanied heperhomocysteinemia. Plasma Hcy levels in patients with T2DM and T2DM accompanied heperhomocysteinemia among different pattern groups were ranked from high to low as follows:yin-yang deficiency pattern, qi-yin deficiency pattern and yin-deficiency and excessive heat pattern, the difference was statistical significance. (P＜O.05)
Conclusion:
1、Based on intensive control of blood glucose, the treatment of Liver-Nourishing and Endogenous Wind-Stopping and Collateral-Unblocking Decoction combined with methylcobalamin has a good and safe effect in patients with DPN. Simultaneously, its effect is superior to only using methylcobalamin.
2、There is certain correlation between plasma Hcy level and TCM patterns in patients with T2DM. Plasma Hcy level can be regarded as a objective index for Traditional Chinese Medicine(TCM)syndrome differentiation in T2DM.
引文
[1]Mermen LI, de Courcy GP, Guilland JC, et al. Homocysteine, cardiovascular disease risk factors, and habitual diet in the French Supplementation with Antioxidant Vitamins and Minerals StudyfJ]. Am J Clin Nutr,2002,76(6):1279-1289.
[2]Ambrosch A, Dierkes J, Lobmann R, et al. Relation between homocysteinaemia and diabetic neuorpathy in patients with type 2 diabetes mellitus[J]. Diabet Med,2001,18(3):185-192.
[3]Ndrepepa G, Kastrati A, Braun S, et al. Circulating homocysteine levels in patients with type 2 diabetes mellitus[J]. Nutr Metab Cardiovasc Dis,2008,18(1):66-73.
[4]Becker A, Smulders YM, van Guldener C, et al. Epidemiology of homocysteine as a risk factor in diabetes[J]. Metab Syndr Relat Disord,2003,1(2):105-120.
[5]De Luis DA, Fernandez N, Arranz ML, et al. Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2[J]. J Diabetes Complications,2005,19:(l):42-46.
[6]张霞,顾秀玉,李美芳.血浆同型半胱氨酸在糖尿病患者中检测的意义[J].中华全科医学,2009,7(11)：1241-1242.
[7]汤正义,李向利,张炜,等.2型糖尿病神经病变的发病情况与有关因素相关性分析[J].中华内科杂志,2003,42(12)：868-869.
[8]陈可冀,史载祥.实用血瘀证学[M].第一版.北京：人民卫生出版社,1999：500-501.
[9]钱秋海,苏勋庄,崔云竹,等.益气养阴化痰活血法治疗糖尿病周围神经病变机制探讨[J].山东中医杂志,2005,24(2)：67-68.
[10]任爱华,阚方旭.萎痹方治疗糖尿病周围神经病变临床观察[J].中国中西医结合杂志,2000,,20(7)：543-544.
[11]徐生生.温阳化瘀法治疗老年糖尿病周围神经病变疗效观察[J].辽宁中医志,2004,31(5)：376.
[12]洪晓华,林惠京.益气温阳、活血通络方药治疗糖尿病周围神经病变疗效观察[J].中国中医急症,2006,15(4)：366-367.
[13]金杰,陈海燕,张芳,等.张发荣教授治疗糖尿病周围神经病变的经验[J].四川中医,2000,18(6)：1-2.
[14]叶仁群,陈泽奇.补肝活血法治疗糖尿病周围神经病变理论探讨[J].中国中医药信息杂志,2005,12(5)：4-5.
[15]刘燕婉.滋肾补肝、活血通络法治疗糖尿病周围神经病变36例[J].甘肃中医,2009,22(9)：21-22.
[16]赵会玲,王建平,刘佳林,等.健脾升清通络汤治疗糖尿病周围神经病变的临床观察[J].陕西中医,2007,28(8)：995-997.
[17]胡孝荣,朱小刚,陈颖,等.血.府逐瘀汤化裁治疗糖尿病周围神经病变的临床研究[J].四川中医, 2005,23(9)：47-49.
[18]周国立,高建军.活络效灵丹治疗糖尿病周围神经病变47例[J].四川中医,2005,23(10)：67.
[19]刘兰霞.血塞通注射液治疗糖尿病周围神经病变33例[J].实用中医内科杂志,2008,22(5)：41.
[20]梁家利,周静,王十伟,等.川芎嗪治疗2型糖尿病周围神经病变63例临床观察[J].新中医,2008,40(3)：24-25.
[21]刘瑞云.补阳还五汤治疗糖尿病周围神经病变48例[J].辽宁中医药大学学报,2009,11(6)：120.
[22]苗桂珍,梁秀珍,王亚红.补气活血.法治疗糖尿病周围神经病变的临床观察[J].中国中西医结合杂志,2003,23(11)：826-828.
[23]武美英,郝立鹏.甲钴胺片联合养阴活血汤治疗糖尿病周围神经病变72例的疗效观察,国际中医中药杂志,2010,32(2)：144-145
[24]陈剑秋,石志芸,王文健,等.益气养阴活血方治疗糖尿病周围神经病变的临床观察[J].上海中医药杂志,2002,36(7)：23-24.
[25]薛红丽,王文健,陈剑秋,等.参麦活血饮对糖尿病大鼠坐骨神经和红细胞山梨醇水平及神经功能的影响[J].中华内分泌代谢杂志,2002,18(6)：484-487.
[26]张秀敏.温脉活血.汤治疗糖尿病周围神经病变38例临床观察[J].江苏中医药,2005,26(6)：22-23.
[27]刘文科,仝小林.仝小林教授应用大剂量毒剧药治疗重症糖尿病周围神经痛验案1例[J].新中医,2010,42(5)：94-95.
[28]刘占萍,吴春玲.补肝汤治疗糖尿病周围神经病变30例[J].陕西中医,2010,31(4)：419-420.
[29]贺钰磊,陈泽奇,叶仁群,等.加味补肝汤对DN大鼠血.清MDA水平及神经节NF-KBp65表达的影响[J].湖南中医学院学报,2006,26(4)：16-19.
[30]周劲勇.补肾活血通络汤治疗糖尿病周围神经病变临床观察[J].湖北中医杂志,2009,31(5)：36-37.
[31]梁晓春,郝伟欣,贾力,等.金匮肾气丸对糖尿病大鼠多元醇代谢的影响[J].北京中医,2002,21(5)：271-273.
[32]周卫惠.健脾祛痰散治疗糖尿病周围神经病变临床观察[J],辽宁中医药大学学报,2008,10(2)：101-102.
[33]何颂华,方邦江,陈浩,等.化痰通络法治疗糖尿病周围神经病变的临床研究[J].上海中医药大学学报,2007,21(4)：35-36.
[34]衡先培,张发荣,谢春光,等.通络糖泰防治糖尿病性周围神经病变的实验研究[J].安徽中医学院学报,2000,19(2)：45-46.
[35]丁淑强.电针刺络拔罐并用治疗糖尿病周围神经病变48例[J].中国中西医结合杂志,2007,27(9)：843.
[36]赵建玲,李忠仁.温和灸治疗糖尿病周围神经病变临床观察[J].中国针灸,2008,28(1)：13-16.
[37]赵美玉,常海.中药浴加手足部穴位按摩治疗糖尿病周围神经病变42例[J].中国中西医结合杂志, 2006,26(11)：1026-1028.
[38]沈琴,顾惠琳,贾伟平,等.上海社区糖尿病及糖调节受损人群周围神经病变的横断面调查[J].上海医学,2009,32(5)：374-378.
[39]高志生,谢国艳.柔肝熄风通络汤治疗糖尿病周围神经病变40例疗效观察[M].实用中医药杂志,2008,24(1)：4-5.
[40]Bruce SG, Young TK. Prevalence and risk factors for neuropathy in a Canadian First Nation community[J]. Diabetes Care,2008,31(9):1837-1841.
[41]施晓红,陈英辉,周连华.高同型半胱氨酸血.症与糖尿病周围神经病变的关系[J].中国糖尿病杂志,2008,16(6)：331-333.
[42]吕仁和.糖尿病及其并发症中西医诊治学[M].人民卫生出版社,1997：391.
[43]中药新药临床研究指导原则(试行)[M].中国医药科技出版社.2002：127.233.
[44]贾建平.神经病学[M].北京：人民卫生出版社,2008.420.
[45]孙磊,陈丽,任建民,等.同型半胱氨酸及其相关酶基因多态性与糖尿病周围神经病变的关系[J].中华内分泌代谢杂志,2004,20(6)：536-537.
[46]王莉梅,张东铭.2型糖尿病患者高Hcy血症与周围神经病变关系研究[J].医药论坛杂志,2009,30(17)：33-34.
[47]王宏利,樊东升,洪天配,等.血清同型半胱氨酸水平与2型糖尿病周围神经病变的关系[J].中国糖尿病杂志,2007,15(5)：299-302.
[48]Becker A, Henry RM, Kostense PJ, et al. Plasma homocysteine and S-adenosylmethionine in erythrocytes as determinants of carotid intima-media thickness:different effects in diabetic and non-diabetic individuals[J]. Atherosclerosis,2003,169(2):323-330.
[49]Blom HJ,'kleinveld HA, Boers GH, et al. Lipid peroxidation and susceptibility of low-density lipoprotein to in vitro oxidation in hyperhomocysteinaemia[J]. Eur J Clin Invest,1995,25(3):149-154.
[50]蒋雯巍,蒋雨平.高同型半胱氨酸血症与糖尿病神经病变[J].中华老年医学杂志,2005,24(9)：708.
[51]Okada E, Oida K, Tada H, et al. Hyperhomocysteinemia is a risk factor for coronary arteriosclerosis in type 2 diabetes[J]. Diabetes Care,1999,22(3):484-490.
[52]彭海,程鹤,邢宏义等.同型半胱氨酸损伤大鼠血脑屏障的机制及维生素干预的效果[J].中华医学杂志,2010,90(23)：1642-1644.
[53]北京弥可保临床观察协作组.钴胺治疗糖尿病神经病变的临床观察[J].中华内科杂志,1999,1(38)：14-17.
[54]于滢.糖尿病周围神经病变的药物治疗[J].天津药学,2006,18(2)：54-57.
[55]凤良元,鄢顺琴,吴愫清,等.芍药甘草汤镇痛作用及机理的实验研究[J].中国实验方剂学杂志,2002,8(1)：23-25.
[56]郑卫红,钱京萍.鸟红天麻种麻对小鼠镇痛作用的实验研究[J].湖北民族学院学报(医学版),2005,22(4)：9-10.
[57]王正荣,罗红琳,肖静,等.天麻索对动脉血管顺应性以及血流动力学的影响[J].生物医学工程学杂志,1994,11(3)：197-201.
[58]Cheng CY, Ho TY, Lee EJ. Ferulic acid reduces cerebral infarct through its antioxidative and anti-inflammatory effects following transient focal cerebral ischemia in rats [J]. Am J Chin Med,2008, 36(6):1105-1119.
[59]Zhang L, Du JR, Wang J, et al. Z-ligustilide extracted from Radix Angelica Sinensis decreased platelet aggregation induced by ADP ex vivo and arterio-venous shunt thrombosis in vivo in rats[J].Yakugaku Zasshi,2009,129(7):855-859.
[60]Kang Y, Hu M, Zhu Y, et al. Antioxidative effect of the herbal remedy Qin Huo Yi Hao and its active component teramethylpyrazine on high glucose-treated endothelial cells[J]. Life Sci,2009,84(13-14): 428-436.
[61]Han JY, Fan JY, Horie Y, et al. Ameliorating effects of compounds derived from Salvia miltiorrhiza root extract on microcirculatory disturbance and reperfusion[J]. Pharmacol Ther,2008,117(2):280-295.
[62]彭延古,李露丹,雷田香,等.僵蚕抗凝成分对血小板聚集的抑制效应[J].血栓与止血学,2007,13(2)：78-79.
[63]李小莉,张迎庆,黄通华.白芥子提取物的抗炎镇痛作用研究[J].现代中药研究与实践,2007,21(6)：28-30.
[64]关颖,李菁,朱伟杰,等.丝瓜络对小鼠心肌缺血性损伤的预防效应[J].中国病理生理杂志,2006,22(1)：68-71.
[65]祝惠民.内科学[M].第4版.北京：人民卫生出版社,2001：401-409.
[66]中华人民共和国卫生部.中药新药临床研究指导原则(第一辑)[M].北京：人民卫生出版社,1993：215-218.
[67]Clarke R, Daly L, Robinson K, et al. Hyperhomocysteinemia:an independent risk factor for vascular disease[J]. N Engl J Med,1991,324(17):1149-1155.
[68]Troughton JA, Woodside JV, Young IS, et al. Homocystenine and coronary heart disease risk in the PRIME study [J]. Atherosclerosis,2007,191(1):90-97.
[69]Ramakrishnan S, Sulochana KN, Lakshmi S, et al. Biochemistry of homocyteine in health and diseases[J]. Indian J Biochem Biophys,2006,43(5):275-283.
[70]郭立新,潘琦,初明峰,等.高同型半胱氨酸血症与糖尿病患者颈动脉内膜中程厚度关系及强化控制的影响.中华内分泌代谢杂志,2006,22(1)：19-22.
[71]吴锦丹,马建华,叶匕,等.高同型半胱氨酸血症与2型糖尿病冠心病.中华内分泌代谢杂志,2004,20(1)：36-38.
[72]卜瑞芳,邓震霞,沈泓,等.血浆同型半胱氨酸水平与2型糖尿病合并脑梗死的关系.中华内分泌代谢杂志,2004,20(5)：444-445.
[73]Meigs JB, Jacques PF, Selhub J. Fasting plasma homocysteine levels in insulin resistence syntrome:the Framingham offspring study[J]. Diabetes Care,2001,24(8):1403-1410.
[74]Fonseca VA, Fink LM, Kern PA. Insulin sensitivity and plasma homocyeteine concentrations in non-diabetic obese and normal weight subjects[J]. Atherosclerosis,2003,167(1):105-109.
[75]Li Y, Jiang C, Xu G, et al. Homocysteine upregulates resistin production from adipocytes in vivo and in vitro[J]. Diabetes,2008,57(4):817-827.
[76]杨国庆,陆菊明,柳红芳,等.吡格列酮对胰岛素抵抗大鼠血浆同型半胱氨酸水平的影响[J].中华内科杂志,2005,44(1)：38-41.
[77]陆宏红,李明珍,华江.高同型半胱氨酸血症与2型糖尿病慢性并发症的关系[J].中国糖尿病杂志,2003,11(5)：357-360.
[78]徐成兴,叶伟成,胡蕴刚,等.120例2型糖尿病患者的中医辨证分型及相关分析[J].上海中医药杂志,2007,41(6)：34-36.
[2]Ambrosch A, Dierkes J, Lobmann R, et al. Relation between homocysteinaemia and diabetic neuorpathy in patients with type 2 diabetes mellitus[J]. Diabet Med,2001,18(3):185-192.
[3]Ndrepepa G, Kastrati A, Braun S, et al. Circulating homocysteine levels in patients with type 2 diabetes mellitus[J]. Nutr Metab Cardiovasc Dis,2008,18(1):66-73.
[4]Becker A, Smulders YM, van Guldener C, et al. Epidemiology of homocysteine as a risk factor in diabetes[J]. Metab Syndr Relat Disord,2003,1(2):105-120.
[5]De Luis DA, Fernandez N, Arranz ML, et al. Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2[J]. J Diabetes Complications,2005,19:(l):42-46.
[6]张霞,顾秀玉,李美芳.血浆同型半胱氨酸在糖尿病患者中检测的意义[J].中华全科医学,2009,7(11)：1241-1242.
[7]汤正义,李向利,张炜,等.2型糖尿病神经病变的发病情况与有关因素相关性分析[J].中华内科杂志,2003,42(12)：868-869.
[8]陈可冀,史载祥.实用血瘀证学[M].第一版.北京：人民卫生出版社,1999：500-501.
[9]钱秋海,苏勋庄,崔云竹,等.益气养阴化痰活血法治疗糖尿病周围神经病变机制探讨[J].山东中医杂志,2005,24(2)：67-68.
[10]任爱华,阚方旭.萎痹方治疗糖尿病周围神经病变临床观察[J].中国中西医结合杂志,2000,,20(7)：543-544.
[11]徐生生.温阳化瘀法治疗老年糖尿病周围神经病变疗效观察[J].辽宁中医志,2004,31(5)：376.
[12]洪晓华,林惠京.益气温阳、活血通络方药治疗糖尿病周围神经病变疗效观察[J].中国中医急症,2006,15(4)：366-367.
[13]金杰,陈海燕,张芳,等.张发荣教授治疗糖尿病周围神经病变的经验[J].四川中医,2000,18(6)：1-2.
[14]叶仁群,陈泽奇.补肝活血法治疗糖尿病周围神经病变理论探讨[J].中国中医药信息杂志,2005,12(5)：4-5.
[15]刘燕婉.滋肾补肝、活血通络法治疗糖尿病周围神经病变36例[J].甘肃中医,2009,22(9)：21-22.
[16]赵会玲,王建平,刘佳林,等.健脾升清通络汤治疗糖尿病周围神经病变的临床观察[J].陕西中医,2007,28(8)：995-997.
[17]胡孝荣,朱小刚,陈颖,等.血.府逐瘀汤化裁治疗糖尿病周围神经病变的临床研究[J].四川中医, 2005,23(9)：47-49.
[18]周国立,高建军.活络效灵丹治疗糖尿病周围神经病变47例[J].四川中医,2005,23(10)：67.
[19]刘兰霞.血塞通注射液治疗糖尿病周围神经病变33例[J].实用中医内科杂志,2008,22(5)：41.
[20]梁家利,周静,王十伟,等.川芎嗪治疗2型糖尿病周围神经病变63例临床观察[J].新中医,2008,40(3)：24-25.
[21]刘瑞云.补阳还五汤治疗糖尿病周围神经病变48例[J].辽宁中医药大学学报,2009,11(6)：120.
[22]苗桂珍,梁秀珍,王亚红.补气活血.法治疗糖尿病周围神经病变的临床观察[J].中国中西医结合杂志,2003,23(11)：826-828.
[23]武美英,郝立鹏.甲钴胺片联合养阴活血汤治疗糖尿病周围神经病变72例的疗效观察,国际中医中药杂志,2010,32(2)：144-145
[24]陈剑秋,石志芸,王文健,等.益气养阴活血方治疗糖尿病周围神经病变的临床观察[J].上海中医药杂志,2002,36(7)：23-24.
[25]薛红丽,王文健,陈剑秋,等.参麦活血饮对糖尿病大鼠坐骨神经和红细胞山梨醇水平及神经功能的影响[J].中华内分泌代谢杂志,2002,18(6)：484-487.
[26]张秀敏.温脉活血.汤治疗糖尿病周围神经病变38例临床观察[J].江苏中医药,2005,26(6)：22-23.
[27]刘文科,仝小林.仝小林教授应用大剂量毒剧药治疗重症糖尿病周围神经痛验案1例[J].新中医,2010,42(5)：94-95.
[28]刘占萍,吴春玲.补肝汤治疗糖尿病周围神经病变30例[J].陕西中医,2010,31(4)：419-420.
[29]贺钰磊,陈泽奇,叶仁群,等.加味补肝汤对DN大鼠血.清MDA水平及神经节NF-KBp65表达的影响[J].湖南中医学院学报,2006,26(4)：16-19.
[30]周劲勇.补肾活血通络汤治疗糖尿病周围神经病变临床观察[J].湖北中医杂志,2009,31(5)：36-37.
[31]梁晓春,郝伟欣,贾力,等.金匮肾气丸对糖尿病大鼠多元醇代谢的影响[J].北京中医,2002,21(5)：271-273.
[32]周卫惠.健脾祛痰散治疗糖尿病周围神经病变临床观察[J],辽宁中医药大学学报,2008,10(2)：101-102.
[33]何颂华,方邦江,陈浩,等.化痰通络法治疗糖尿病周围神经病变的临床研究[J].上海中医药大学学报,2007,21(4)：35-36.
[34]衡先培,张发荣,谢春光,等.通络糖泰防治糖尿病性周围神经病变的实验研究[J].安徽中医学院学报,2000,19(2)：45-46.
[35]丁淑强.电针刺络拔罐并用治疗糖尿病周围神经病变48例[J].中国中西医结合杂志,2007,27(9)：843.
[36]赵建玲,李忠仁.温和灸治疗糖尿病周围神经病变临床观察[J].中国针灸,2008,28(1)：13-16.
[37]赵美玉,常海.中药浴加手足部穴位按摩治疗糖尿病周围神经病变42例[J].中国中西医结合杂志, 2006,26(11)：1026-1028.
[38]沈琴,顾惠琳,贾伟平,等.上海社区糖尿病及糖调节受损人群周围神经病变的横断面调查[J].上海医学,2009,32(5)：374-378.
[39]高志生,谢国艳.柔肝熄风通络汤治疗糖尿病周围神经病变40例疗效观察[M].实用中医药杂志,2008,24(1)：4-5.
[40]Bruce SG, Young TK. Prevalence and risk factors for neuropathy in a Canadian First Nation community[J]. Diabetes Care,2008,31(9):1837-1841.
[41]施晓红,陈英辉,周连华.高同型半胱氨酸血.症与糖尿病周围神经病变的关系[J].中国糖尿病杂志,2008,16(6)：331-333.
[42]吕仁和.糖尿病及其并发症中西医诊治学[M].人民卫生出版社,1997：391.
[43]中药新药临床研究指导原则(试行)[M].中国医药科技出版社.2002：127.233.
[44]贾建平.神经病学[M].北京：人民卫生出版社,2008.420.
[45]孙磊,陈丽,任建民,等.同型半胱氨酸及其相关酶基因多态性与糖尿病周围神经病变的关系[J].中华内分泌代谢杂志,2004,20(6)：536-537.
[46]王莉梅,张东铭.2型糖尿病患者高Hcy血症与周围神经病变关系研究[J].医药论坛杂志,2009,30(17)：33-34.
[47]王宏利,樊东升,洪天配,等.血清同型半胱氨酸水平与2型糖尿病周围神经病变的关系[J].中国糖尿病杂志,2007,15(5)：299-302.
[48]Becker A, Henry RM, Kostense PJ, et al. Plasma homocysteine and S-adenosylmethionine in erythrocytes as determinants of carotid intima-media thickness:different effects in diabetic and non-diabetic individuals[J]. Atherosclerosis,2003,169(2):323-330.
[49]Blom HJ,'kleinveld HA, Boers GH, et al. Lipid peroxidation and susceptibility of low-density lipoprotein to in vitro oxidation in hyperhomocysteinaemia[J]. Eur J Clin Invest,1995,25(3):149-154.
[50]蒋雯巍,蒋雨平.高同型半胱氨酸血症与糖尿病神经病变[J].中华老年医学杂志,2005,24(9)：708.
[51]Okada E, Oida K, Tada H, et al. Hyperhomocysteinemia is a risk factor for coronary arteriosclerosis in type 2 diabetes[J]. Diabetes Care,1999,22(3):484-490.
[52]彭海,程鹤,邢宏义等.同型半胱氨酸损伤大鼠血脑屏障的机制及维生素干预的效果[J].中华医学杂志,2010,90(23)：1642-1644.
[53]北京弥可保临床观察协作组.钴胺治疗糖尿病神经病变的临床观察[J].中华内科杂志,1999,1(38)：14-17.
[54]于滢.糖尿病周围神经病变的药物治疗[J].天津药学,2006,18(2)：54-57.
[55]凤良元,鄢顺琴,吴愫清,等.芍药甘草汤镇痛作用及机理的实验研究[J].中国实验方剂学杂志,2002,8(1)：23-25.
[56]郑卫红,钱京萍.鸟红天麻种麻对小鼠镇痛作用的实验研究[J].湖北民族学院学报(医学版),2005,22(4)：9-10.
[57]王正荣,罗红琳,肖静,等.天麻索对动脉血管顺应性以及血流动力学的影响[J].生物医学工程学杂志,1994,11(3)：197-201.
[58]Cheng CY, Ho TY, Lee EJ. Ferulic acid reduces cerebral infarct through its antioxidative and anti-inflammatory effects following transient focal cerebral ischemia in rats [J]. Am J Chin Med,2008, 36(6):1105-1119.
[59]Zhang L, Du JR, Wang J, et al. Z-ligustilide extracted from Radix Angelica Sinensis decreased platelet aggregation induced by ADP ex vivo and arterio-venous shunt thrombosis in vivo in rats[J].Yakugaku Zasshi,2009,129(7):855-859.
[60]Kang Y, Hu M, Zhu Y, et al. Antioxidative effect of the herbal remedy Qin Huo Yi Hao and its active component teramethylpyrazine on high glucose-treated endothelial cells[J]. Life Sci,2009,84(13-14): 428-436.
[61]Han JY, Fan JY, Horie Y, et al. Ameliorating effects of compounds derived from Salvia miltiorrhiza root extract on microcirculatory disturbance and reperfusion[J]. Pharmacol Ther,2008,117(2):280-295.
[62]彭延古,李露丹,雷田香,等.僵蚕抗凝成分对血小板聚集的抑制效应[J].血栓与止血学,2007,13(2)：78-79.
[63]李小莉,张迎庆,黄通华.白芥子提取物的抗炎镇痛作用研究[J].现代中药研究与实践,2007,21(6)：28-30.
[64]关颖,李菁,朱伟杰,等.丝瓜络对小鼠心肌缺血性损伤的预防效应[J].中国病理生理杂志,2006,22(1)：68-71.
[65]祝惠民.内科学[M].第4版.北京：人民卫生出版社,2001：401-409.
[66]中华人民共和国卫生部.中药新药临床研究指导原则(第一辑)[M].北京：人民卫生出版社,1993：215-218.
[67]Clarke R, Daly L, Robinson K, et al. Hyperhomocysteinemia:an independent risk factor for vascular disease[J]. N Engl J Med,1991,324(17):1149-1155.
[68]Troughton JA, Woodside JV, Young IS, et al. Homocystenine and coronary heart disease risk in the PRIME study [J]. Atherosclerosis,2007,191(1):90-97.
[69]Ramakrishnan S, Sulochana KN, Lakshmi S, et al. Biochemistry of homocyteine in health and diseases[J]. Indian J Biochem Biophys,2006,43(5):275-283.
[70]郭立新,潘琦,初明峰,等.高同型半胱氨酸血症与糖尿病患者颈动脉内膜中程厚度关系及强化控制的影响.中华内分泌代谢杂志,2006,22(1)：19-22.
[71]吴锦丹,马建华,叶匕,等.高同型半胱氨酸血症与2型糖尿病冠心病.中华内分泌代谢杂志,2004,20(1)：36-38.
[72]卜瑞芳,邓震霞,沈泓,等.血浆同型半胱氨酸水平与2型糖尿病合并脑梗死的关系.中华内分泌代谢杂志,2004,20(5)：444-445.
[73]Meigs JB, Jacques PF, Selhub J. Fasting plasma homocysteine levels in insulin resistence syntrome:the Framingham offspring study[J]. Diabetes Care,2001,24(8):1403-1410.
[74]Fonseca VA, Fink LM, Kern PA. Insulin sensitivity and plasma homocyeteine concentrations in non-diabetic obese and normal weight subjects[J]. Atherosclerosis,2003,167(1):105-109.
[75]Li Y, Jiang C, Xu G, et al. Homocysteine upregulates resistin production from adipocytes in vivo and in vitro[J]. Diabetes,2008,57(4):817-827.
[76]杨国庆,陆菊明,柳红芳,等.吡格列酮对胰岛素抵抗大鼠血浆同型半胱氨酸水平的影响[J].中华内科杂志,2005,44(1)：38-41.
[77]陆宏红,李明珍,华江.高同型半胱氨酸血症与2型糖尿病慢性并发症的关系[J].中国糖尿病杂志,2003,11(5)：357-360.
[78]徐成兴,叶伟成,胡蕴刚,等.120例2型糖尿病患者的中医辨证分型及相关分析[J].上海中医药杂志,2007,41(6)：34-36.